Pfizer set to oust AstraZeneca as top supplier of Covid-19 shots to poor nations
Skip to main content
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
  • Epaper
  • More
    • Subscribe
    • COVID-19
    • Bangladesh
    • Splash
    • Videos
    • Games
    • Long Read
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
The Business Standard

Wednesday
June 29, 2022

Sign In
Subscribe
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
  • Epaper
  • More
    • Subscribe
    • COVID-19
    • Bangladesh
    • Splash
    • Videos
    • Games
    • Long Read
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
WEDNESDAY, JUNE 29, 2022
Pfizer set to oust AstraZeneca as top supplier of Covid-19 shots to poor nations

Coronavirus chronicle

Reuters
15 December, 2021, 04:35 pm
Last modified: 15 December, 2021, 04:41 pm

Related News

  • Who managed Covid-19 best, and why?
  • Children aged 5-12 yrs to get Pfizer vaccine 
  • Bangladesh gets another 4m Covid jabs from US
  • India’s daily Covid tally declines with 15,940 cases, 20 new deaths added
  • Beijing says will reopen primary, secondary schools as Covid cases recede

Pfizer set to oust AstraZeneca as top supplier of Covid-19 shots to poor nations

The expected change comes with headaches for receiving countries that lack sufficient cold storage capacity to handle the Pfizer vaccine, and amid risks of a shortage of syringes needed to administer that shot

Reuters
15 December, 2021, 04:35 pm
Last modified: 15 December, 2021, 04:41 pm
A vial labelled with the Pfizer-BioNTech coronavirus disease (Covid-19) vaccine is seen in this illustration picture taken March 19, 2021. Photo :Reuters
A vial labelled with the Pfizer-BioNTech coronavirus disease (Covid-19) vaccine is seen in this illustration picture taken March 19, 2021. Photo :Reuters

Summary:

  • In big shift, Covax to supply more Pfizer doses than AstraZeneca
  • By March next year, Pfizer expected to be top supplier
  • Pfizer doses more difficult to deliver in poorer nations
  • Insufficient cold chain, shortage of syringes among main risks

Pfizer and BioNtech are set to displace AstraZeneca as the main suppliers of Covid-19 vaccines to the global COVAX programme at the start of 2022, a shift that shows the increasing importance of their shot for poorer states.

The expected change comes with headaches for receiving countries that lack sufficient cold storage capacity to handle the Pfizer vaccine, and amid risks of a shortage of syringes needed to administer that shot.

AstraZeneca is currently the most distributed vaccine by COVAX, according to data from Gavi, the vaccine alliance that co-manages the programme with the World Health Organization (WHO).

The programme has so far delivered more than 600 million shots to nearly 150 countries, of which more than 220 million are AstraZeneca's and about 160 million Pfizer's.

But in the first quarter of next year Pfizer is set to take over, according to Gavi and WHO figures on doses assigned by the COVAX programme for future supplies.

By the end of March, another 150 million Pfizer doses are to be distributed by COVAX, a WHO document shows.

A spokesperson for Gavi confirmed that Pfizer is far ahead in terms of "allocated" jabs, with about 470 million doses delivered or readied for delivery, against 350 million from AstraZeneca.

Pfizer is the first provider of Covid-19 vaccines to the European Union, the United States and Japan.

It has bilateral agreements for more than 6 billion doses, making it by far the largest supplier of Covid-19 vaccines, according to data from UNICEF, a UN agency.

But AstraZeneca has been seen as a crucial supplier to less developed countries, because its shot is cheaper and easier to deliver.

COVAX bet heavily on AstraZeneca at the beginning of the pandemic, but supply problems and export restrictions from top producer India gradually reduced its reliance on the Anglo-Swedish shot.

As the programme faced problems in securing doses directly from vaccine makers amid a global scramble for shots, donations from rich nations became more important, turning Pfizer into the main supplier to COVAX. The United States is donating mostly Pfizer shots to the programme.

Cold chain and syringes 

The change forced Gavi to rush to invest more in cold chain capacity in receiving countries that do not have enough refrigerators and cold transport equipment to handle the Pfizer shot, which requires lower storage temperatures than the AstraZeneca vaccine.

The organization warned about insufficient cold chain capacity in some countries, according to an internal report submitted to Gavi's board at the beginning of December and seen by Reuters.

The problem is compounded by a risk of shortages of special syringes needed to administer the Pfizer vaccine, Gavi warned in the document.

The Pfizer jab is "the hardest to deliver given ultra-cold chain and special syringe requirements", Gavi says in its internal document.

It is also "the hardest to plan for as these (donated vaccines) often come with earmarking and little notice or in a staggered manner and in small volumes and with short shelf lives", the document says.

Wealthy countries donating Covid-19 vaccines with a relatively short shelf life has been a "major problem" for COVAX, a WHO official said last week, as many doses were wasted.

An EU official told a news briefing last week that EU donations of Pfizer vaccines to COVAX were slowed by a lack of syringes. A second official familiar with the issue told Reuters that Gavi had to postpone the delivery of some Pfizer doses from Europe because of the lack of syringes.

Pfizer declined to comment on syringes because it said it does not produce or buy them directly.

As more doses are made available to poorer nations, UNICEF and the WHO have long been warning of the insufficient supply of the auto-disable syringes, which are crucial for inoculations in poorer nations. 

Auto-disable syringes lock automatically to prevent re-use, which is otherwise common in poorer nations and could spread of diseases. To make things more complicated, auto-disable syringes needed for the Pfizer vaccine are different from standard syringes, UNICEF said.

Top News / World+Biz

COVID-19 / Covid-19 Vaccine / Covid-19 Vaccine donations / Pfizer / Pfizer COVID vaccine / Pfizer Inc / Pfizer vaccine / AstraZeneca

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Penalty for non-disclosure of offshore assets: Budget FY23
    Penalty for non-disclosure of offshore assets: Budget FY23
  • A view of Gulshan area in Dhaka. Photo: Wikimedia
    Dhaka ranks as costliest city again in South Asia for expatriates: Survey
  • Photo: Mumit M/TBS
    Govt mulls banning bikes on Dhaka-Mawa-Bhanga highway

MOST VIEWED

  • A woman holds a small bottle labelled with a "Coronavirus COVID-19 Vaccine" sticker and a medical syringe in this illustration taken October 30, 2020. REUTERS/Dado Ruvic/File Photo
    S Korea approves first domestically developed Covid vaccine
  • Photo: Collected
    US medical experts call for Omicron-specific Covid boosters
  • David E Adler. Sketch: TBS
    Who managed Covid-19 best, and why?
  • People line up at a nucleic acid testing station, following the coronavirus disease (COVID-19) outbreak, in Beijing, China, June 16, 2022. REUTERS/Thomas Peter/File Photo
    China slashes Covid quarantine time for international travellers
  • Covid-19 deaths were reported from Gorakhpur, Jalaun, Bulandshahr, Kannauj, Sonbhadra, Gonda, Bhadohi, Basti, Kushinagar and Mau (HT Photo)
    India sees 45% jump in a day with 17,073 new Covid cases
  • A healthcare worker collects the nasal sample of a policeman for Covid testing in Jammu on Wednesday. (ANI Photo)
    India’s daily Covid tally declines with 15,940 cases, 20 new deaths added

Related News

  • Who managed Covid-19 best, and why?
  • Children aged 5-12 yrs to get Pfizer vaccine 
  • Bangladesh gets another 4m Covid jabs from US
  • India’s daily Covid tally declines with 15,940 cases, 20 new deaths added
  • Beijing says will reopen primary, secondary schools as Covid cases recede

Features

Mahathir accused financial titans of seeking to reverse decades of economic development that propelled tens of millions into the middle class. Photo: Bloomberg

George Soros, Mahathir and the legacy of 1997

4h | Panorama
 If Bangladesh produces and exports high-value-added MMF products right now, we can increase our total export by around 25% in value. Photo: Mumit M

Time ripe for Bangladesh RMG sector to focus more on man-made fibres

8h | Panorama
Human Library Bangladesh has organised so far nine sessions; eight have been held in different parts of Dhaka and one in Khulna. Photo: Courtesy

Human Library Bangladesh: Where the halls come alive with human voices

9h | Panorama
Abortion is a part of healthcare. Photo: Bloomberg

Abortion is healthcare and women’s rights are human rights

1d | Panorama

More Videos from TBS

Beautiful mural at Padma bridge

Beautiful mural at Padma bridge

1h | Videos
Ferry terminals wear deserted look, traders fear losses

Ferry terminals wear deserted look, traders fear losses

2h | Videos
Top 10: World’s longest bridges

Top 10: World’s longest bridges

3h | Videos
Archeological artefacts getting ruined locked in store room

Archeological artefacts getting ruined locked in store room

8h | Videos

Most Read

1
Padma Bridge from satellite. Photo: Screengrab
Bangladesh

Padma Bridge from satellite 

2
Photo: TBS
Bangladesh

Motorcycles banned on Padma Bridge 

3
Japan cancels financing Matarbari coal project phase 2
Bangladesh

Japan cancels financing Matarbari coal project phase 2

4
Photo: Courtesy
Corporates

Gree AC being used in all parts of Padma Bridge project

5
Photo: TBS
Infrastructure

Gains from Padma Bridge to cross $10b, hope experts

6
Desco wanted to make a bold statement with their new head office building, a physical entity that would be a corporate icon. Photo: Courtesy
Habitat

Desco head office: When commitment to community and environment inspires architecture

EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Privacy Policy
  • Comment Policy
Copyright © 2022
The Business Standard All rights reserved
Technical Partner: RSI Lab
BENEATH THE SURFACE
An aerial view of a MRT Line-6 construction site. Work on the first elevated metro rail of Bangladesh is going on in full swing. A total of 16 elevated stations will connect the capital’s Uttara to Motijheel via Mirpur, Farmgate and Dhaka University. The photo was taken from Farmgate area recently. Photo: Rajib Dhar

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net